BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06112379-completion@plaintrial.com
DTSTAMP:20261029T083035Z
DTSTART;VALUE=DATE:20320923
SUMMARY:A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab fo
 r Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-lo
 w/HER2-negative Breast Cancer — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT06112379
URL:https://plaintrial.com/trial/NCT06112379
END:VEVENT
END:VCALENDAR